新光药业
(300519)
| 流通市值：16.42亿 | | | 总市值：23.02亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 210,958,037 | 142,593,090.09 | 88,469,330.56 | 265,359,823.7 |
| 营业总成本 | 141,623,596.13 | 101,939,916.61 | 59,792,683.17 | 208,296,602.07 |
| 其他经营收益 | | | | |
| 营业利润 | 74,777,114.74 | 45,398,616.27 | 30,467,871.49 | 64,864,262.64 |
| 利润总额 | 73,763,316.47 | 45,456,188 | 30,467,871.49 | 63,427,072.98 |
| 净利润 | 64,100,161.06 | 39,712,072.46 | 26,367,975.34 | 54,211,458.52 |
| 每股收益 | | | | |
| 其他综合收益 | -225,778.44 | -866,110.88 | -122,750.41 | 67,953.34 |
| 综合收益总额 | 63,874,382.62 | 38,845,961.58 | 26,245,224.93 | 54,279,411.86 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 803,436,840.56 | 773,587,330.49 | 808,487,676.88 | 767,340,354.61 |
| 非流动资产: | | | | |
| 非流动资产合计 | 106,404,018.25 | 108,858,569.54 | 112,914,143.44 | 122,075,764.98 |
| 资产总计 | 909,840,858.81 | 882,445,900.03 | 921,401,820.32 | 889,416,119.59 |
| 流动负债: | | | | |
| 流动负债合计 | 48,830,175.33 | 46,155,849.58 | 49,365,199.47 | 44,709,675.9 |
| 非流动负债: | | | | |
| 非流动负债合计 | 6,949,059.4 | 7,256,847.41 | 7,604,154.46 | 7,895,202.23 |
| 负债合计 | 55,779,234.73 | 53,412,696.99 | 56,969,353.93 | 52,604,878.13 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 854,061,624.08 | 829,033,203.04 | 864,432,466.39 | 836,811,241.46 |
| 股东权益合计 | 854,061,624.08 | 829,033,203.04 | 864,432,466.39 | 836,811,241.46 |
| 负债和股东权益合计 | 909,840,858.81 | 882,445,900.03 | 921,401,820.32 | 889,416,119.59 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 210,094,782.77 | 144,142,560.78 | 95,596,532.26 | 282,831,674.07 |
| 经营活动现金流出小计 | 135,897,885.11 | 86,364,272.21 | 43,792,838.02 | 213,907,179.44 |
| 经营活动产生的现金流量净额 | 74,196,897.66 | 57,778,288.57 | 51,803,694.24 | 68,924,494.63 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 501,433,445.58 | 440,621,505.03 | 147,939,551.05 | 640,971,145.95 |
| 投资活动现金流出小计 | 460,399,976.75 | 430,211,346.75 | 90,053,746.75 | 853,475,750.9 |
| 投资活动产生的现金流量净额 | 41,033,468.83 | 10,410,158.28 | 57,885,804.3 | -212,504,604.95 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,000,000 | 1,000,000 | - | 1,000,000 |
| 筹资活动现金流出小计 | 49,000,000 | 49,000,000 | - | 49,000,000 |
| 筹资活动产生的现金流量净额 | -48,000,000 | -48,000,000 | - | -48,000,000 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 67,230,366.49 | 20,188,446.85 | 109,689,498.54 | -191,580,110.32 |
| 期末现金及现金等价物余额 | 379,066,381.63 | 332,024,461.99 | 421,525,513.68 | 311,836,015.14 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 20,188,446.85 | - | -191,580,110.32 |